A detailed history of First Premier Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, First Premier Bank holds 533 shares of LLY stock, worth $417,429. This represents 0.12% of its overall portfolio holdings.

Number of Shares
533
Previous 561 4.99%
Holding current value
$417,429
Previous $508,000 7.09%
% of portfolio
0.12%
Previous 0.14%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$772.14 - $960.02 $21,619 - $26,880
-28 Reduced 4.99%
533 $472,000
Q2 2024

Jul 17, 2024

BUY
$724.87 - $909.04 $3,624 - $4,545
5 Added 0.9%
561 $508,000
Q1 2024

Apr 12, 2024

BUY
$592.2 - $792.28 $13,620 - $18,222
23 Added 4.32%
556 $432,000
Q4 2023

Jan 17, 2024

BUY
$525.19 - $619.13 $525 - $619
1 Added 0.19%
533 $311,000
Q2 2023

Jul 13, 2023

SELL
$350.74 - $468.98 $1,753 - $2,344
-5 Reduced 0.93%
532 $249,000
Q1 2023

Apr 10, 2023

SELL
$310.63 - $364.82 $27,956 - $32,833
-90 Reduced 14.35%
537 $185,000
Q4 2022

Jan 17, 2023

BUY
$321.55 - $374.67 $10,289 - $11,989
32 Added 5.38%
627 $230,000
Q1 2022

Apr 25, 2022

BUY
$234.69 - $291.66 $35,203 - $43,749
150 Added 33.71%
595 $171,000
Q2 2021

Jul 14, 2021

BUY
$180.55 - $233.54 $80,344 - $103,925
445 New
445 $102,000
Q3 2020

Oct 06, 2020

SELL
$146.22 - $169.13 $14,622 - $16,913
-100 Closed
0 $0
Q2 2020

Jul 07, 2020

SELL
$136.42 - $164.18 $6,820 - $8,209
-50 Reduced 33.33%
100 $16,000
Q3 2019

Oct 10, 2019

BUY
$106.79 - $116.16 $16,018 - $17,424
150 New
150 $17,000
Q2 2019

Jul 09, 2019

SELL
$110.79 - $129.32 $8,863 - $10,345
-80 Closed
0 $0
Q4 2018

Jan 14, 2019

BUY
$105.9 - $118.64 $8,472 - $9,491
80 New
80 $9,000
Q3 2018

Oct 09, 2018

SELL
$85.86 - $107.31 $7,298 - $9,121
-85 Closed
0 $0
Q3 2017

Oct 13, 2017

BUY
$77.07 - $85.54 $6,550 - $7,270
85
85 $7,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track First Premier Bank Portfolio

Follow First Premier Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Premier Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Premier Bank with notifications on news.